Composition and method of stem cells for preservation of cardiac tissue
The present disclosure describes a method and composition for enhancing the survival of hematopoietic stem cells, preferably CD34+ derived from human umbilical cord or peripheral blood, in hypoxic and serum-deprived conditions by cultivating the cells in medium containing lysophosphatidic acid, preferably further comprising a gel, namely a biomimetic gel. The method and composition may be used in medicine or cosmetic application, in particular, in treatment of cardiac tissue and/or cardiac diseases, and/or in the treatment of wound healing namely diabetic wound healing.
1. A method for enhancing the survival of hematopoietic stem cells in hypoxic and serum-deprived conditions, the method comprising cultivating the hematopoietic stem cells in a medium containing lysophosphatidic acid, wherein the concentration of lysophosphatidic acid is 100 μM, so as to enhance the survival of the hematopoietic stem cells in hypoxic and serum-deprived conditions.
2. The method according to claim 1 wherein the hematopoietic stem cells are CD34+ cells.